APO GO AMPOULES

Apo Go Ampoules Adverse Events Reported to the FDA Over Time

How are Apo Go Ampoules adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Apo Go Ampoules, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Apo Go Ampoules is flagged as the suspect drug causing the adverse event.

Most Common Apo Go Ampoules Adverse Events Reported to the FDA

What are the most common Apo Go Ampoules adverse events reported to the FDA?

Death	76 (10.63%)
Hallucination	18 (2.52%)
Fall	15 (2.1%)
Muscle Rigidity	15 (2.1%)
Somnolence	13 (1.82%)
Confusional State	12 (1.68%)
Psychotic Disorder	12 (1.68%)
Condition Aggravated	11 (1.54%)
Hyperkinesia	11 (1.54%)
Loss Of Consciousness	10 (1.4%)
General Physical Health Deteriorati...	9 (1.26%)
	Show More
Nodule	9 (1.26%)
Fatigue	8 (1.12%)
Malaise	8 (1.12%)
Nausea	8 (1.12%)
Drug Ineffective	7 (.98%)
Infusion Site Mass	7 (.98%)
Pneumonia	7 (.98%)
Aggression	6 (.84%)
Dyskinesia	6 (.84%)
Haemoglobin Decreased	6 (.84%)
Hallucination, Visual	6 (.84%)
Infusion Site Necrosis	6 (.84%)
Injection Site Inflammation	6 (.84%)
Abscess	5 (.7%)
Anaemia Haemolytic Autoimmune	5 (.7%)
Depression	5 (.7%)
Device Malfunction	5 (.7%)
Disease Progression	5 (.7%)
Hospitalisation	5 (.7%)
Hypertension	5 (.7%)
Incorrect Dose Administered	5 (.7%)
Inflammation	5 (.7%)
Muscle Spasms	5 (.7%)
Pain	5 (.7%)
Vomiting	5 (.7%)
Abdominal Wall Haematoma	4 (.56%)
Accidental Overdose	4 (.56%)
Agitation	4 (.56%)
Cellulitis	4 (.56%)
Diarrhoea	4 (.56%)
Injection Site Haematoma	4 (.56%)
Injection Site Nodule	4 (.56%)
Syncope	4 (.56%)
Urinary Tract Infection	4 (.56%)
Abnormal Behaviour	3 (.42%)
Anxiety	3 (.42%)
Cardiac Disorder	3 (.42%)
Cardiac Failure	3 (.42%)
Circulatory Collapse	3 (.42%)
Dementia	3 (.42%)
Dermatitis Allergic	3 (.42%)
Drug Effect Decreased	3 (.42%)
Erythema	3 (.42%)
Femoral Neck Fracture	3 (.42%)
General Physical Condition Abnormal	3 (.42%)
Headache	3 (.42%)
Hypotension	3 (.42%)
Incontinence	3 (.42%)
Infusion Site Abscess	3 (.42%)
Injection Site Erythema	3 (.42%)
Memory Impairment	3 (.42%)
Mobility Decreased	3 (.42%)
Narcolepsy	3 (.42%)
No Therapeutic Response	3 (.42%)
Oedema	3 (.42%)
Oedema Peripheral	3 (.42%)
Paranoia	3 (.42%)
Pyrexia	3 (.42%)
Respiratory Arrest	3 (.42%)
Skin Discolouration	3 (.42%)
Skin Nodule	3 (.42%)
Tremor	3 (.42%)
Accident	2 (.28%)
Altered State Of Consciousness	2 (.28%)
Apathy	2 (.28%)
Balance Disorder	2 (.28%)
Blood Pressure Decreased	2 (.28%)
Blood Pressure Fluctuation	2 (.28%)
Cerebral Infarction	2 (.28%)
Coma	2 (.28%)
Completed Suicide	2 (.28%)
Contusion	2 (.28%)
Dehydration	2 (.28%)
Delusion	2 (.28%)
Delusional Disorder, Unspecified Ty...	2 (.28%)
Dependence	2 (.28%)
Depressed Mood	2 (.28%)
Disturbance In Attention	2 (.28%)
Dizziness	2 (.28%)
Dysarthria	2 (.28%)
Dysphagia	2 (.28%)
Erection Increased	2 (.28%)
Feeling Hot	2 (.28%)
Gangrene	2 (.28%)
Haematoma	2 (.28%)
Haemolytic Anaemia	2 (.28%)
Hepatitis C	2 (.28%)
Hypokalaemia	2 (.28%)
Impulse-control Disorder	2 (.28%)
Inappropriate Schedule Of Drug Admi...	2 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Apo Go Ampoules, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Apo Go Ampoules is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Apo Go Ampoules

What are the most common Apo Go Ampoules adverse events reported to the FDA?

Fatal Outcomes	76 (10.63%)
Administration Site Reactions	48 (6.71%)
Neurological	44 (6.15%)
Disturbances In Thinking	29 (4.06%)
Infections - Pathogen Unspecified	29 (4.06%)
Movement Disorders	25 (3.5%)
Injuries	22 (3.08%)
Muscle	21 (2.94%)
Gastrointestinal Signs	17 (2.38%)
Schizophrenia And Other Psychotic	15 (2.1%)
Epidermal And Dermal Conditions	14 (1.96%)
	Show More
Medication Errors	14 (1.96%)
Deliria	13 (1.82%)
Therapeutic And Nontherapeutic Effe...	13 (1.82%)
Hematology Investigations	11 (1.54%)
Bacterial Infectious	10 (1.4%)
Hemolyses And Related Conditions	9 (1.26%)
Personality Disorders	9 (1.26%)
Tissue	9 (1.26%)
Decreased And Nonspecific Blood Pre...	8 (1.12%)
Mental Impairment	8 (1.12%)
Respiratory	8 (1.12%)
Urinary Tract Signs	8 (1.12%)
Anxiety Disorders	7 (.98%)
Depressed Mood Disorders	7 (.98%)
Lower Respiratory Tract Disorders	6 (.84%)
Musculoskeletal And Connective Tiss...	6 (.84%)
Skin And Subcutaneous Tissue	6 (.84%)
Therapeutic Procedures And Supporti...	6 (.84%)
Bone And Joint Injuries	5 (.7%)
Procedural And Device Related Injur...	5 (.7%)
Psychiatric	5 (.7%)
Psychiatric And Behavioural Symptom...	5 (.7%)
Sleep Disorders	5 (.7%)
Vascular Hypertensive	5 (.7%)
Abdominal Hernias And Other Abdomin...	4 (.56%)
Body Temperature Conditions	4 (.56%)
Cardiac Disorder Signs	4 (.56%)
Central Nervous System Vascular	4 (.56%)
Electrolyte And Fluid Balance Condi...	4 (.56%)
Gastrointestinal Motility And Defec...	4 (.56%)
Heart Failures	4 (.56%)
Metastases	4 (.56%)
Mood Disorders	4 (.56%)
Physical Examination Topics	4 (.56%)
Sleep Disturbances	4 (.56%)
Gastrointestinal Conditions	3 (.42%)
Headaches	3 (.42%)
Hepatobiliary	3 (.42%)
Impulse Control	3 (.42%)
Lifestyle Issues	3 (.42%)
Metabolic, Nutritional And Blood Ga...	3 (.42%)
Suicidal And Self-injurious Behavio...	3 (.42%)
Anal And Rectal Conditions	2 (.28%)
Appetite And General Nutritional	2 (.28%)
Arteriosclerosis, Stenosis, Vascula...	2 (.28%)
Cardiac And Vascular Investigations	2 (.28%)
Coronary Artery	2 (.28%)
Gallbladder	2 (.28%)
Joint	2 (.28%)
Legal Issues	2 (.28%)
Manic And Bipolar Mood Disorders	2 (.28%)
Ocular Infections, Irritations And ...	2 (.28%)
Pulmonary Vascular	2 (.28%)
Renal Disorders	2 (.28%)
Sexual Dysfunctions, Disturbances A...	2 (.28%)
Sexual Function And Fertility	2 (.28%)
Vascular Hemorrhagic	2 (.28%)
Viral Infectious	2 (.28%)
Allergic Conditions	1 (.14%)
Bone And Joint Therapeutic Procedur...	1 (.14%)
Bronchial Disorders	1 (.14%)
Cardiac Arrhythmias	1 (.14%)
Changes In Physical Activity	1 (.14%)
Embolism And Thrombosis	1 (.14%)
Enzyme	1 (.14%)
Eye	1 (.14%)
Gastrointestinal Hemorrhages	1 (.14%)
Gastrointestinal Inflammatory Condi...	1 (.14%)
Gastrointestinal Neoplasms Malignan...	1 (.14%)
Hepatic And Hepatobiliary	1 (.14%)
Lymphomas	1 (.14%)
Malabsorption Conditions	1 (.14%)
Miscellaneous And Site Unspecified ...	1 (.14%)
Nervous System Neoplasms Malignant ...	1 (.14%)
Protein And Chemistry Analyses	1 (.14%)
Salivary Gland Conditions	1 (.14%)
Seizures	1 (.14%)
Skin Appendage Conditions	1 (.14%)
Vascular	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Apo Go Ampoules, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Apo Go Ampoules is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.